Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein...
Day: November 14, 2026
Cerenome Reports Third Quarter 2026 Financial Results and Business Highlights Featuring REYOBIQ ReSPECT- LM Data and CNSide Commercial and Reimbursement Progress
HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company advancing...
BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update
FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC...
Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
- Continued to advance the development of CLD-401 towards the clinic - Presented new CLD-401 data and in situ...
Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update
Exclusively licensed Senlang’s CD7-Targeted lentiviral in vivo CAR-T platform following initial Phase 1 results with lead BCMA/GPRC5D candidate TPST-4903 Secured...
Cingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission
Manufacturing Work Addressing FDA CMC Information Requests Substantially Completed NDA Resubmission Expected Between December 2026 and January 2027 KANSAS CITY,...
Natural Alternatives International, Inc. Announces Fiscal 2027 Q1 Results
CARLSBAD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and...
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company,...
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company,...
Gaine Expands Consent and Preference Management Solution Across Healthcare Markets
Building on proven success in pharmaceutical and life sciences, Gaine introduces enterprise-wide consent and preference management for healthcare payers and...